PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7076797-9	1982	Gel isoelectric focusing of VLDL before and after nicotinic acid in types IIb and IV hyperlipidemia produced a significant increase in the VLDL ApoC-II component with simultaneous decreases in the total VLDL ApoC-III subspecies.	Niacin	50-64	apolipoprotein C2	Homo sapiens	144-151	
22304839-10	2012	A number of pharmaceutical interventions, including statins, fibrates, ezetimibe, nicotinic acid, and orlistat, have been shown to reduce the increased apoC-II concentrations.	Niacin	82-96	apolipoprotein C2	Homo sapiens	152-159	
213088-0	1978	Relative increase in apolipoprotein CII content of VLDL and chylomicrons in a case with massive type V hyperlipoproteinaemia by nicotinic acid treatment.	Niacin	128-142	apolipoprotein C2	Homo sapiens	21-39